The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sai Sudhakar Vankineni
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Sudhakar Vankineni, a promoter of Oxygenta Pharmaceutical Ltd, sold 2,00,000 equity shares (0.54% of total capital) on April 17, 2025. The sale was executed through a Share Purchase Agreement dated September 30, 2024, making it an off-market transaction rather than an open market sale. Post-sale, the promoter's holding fell sharply from 0.62% (2,30,000 shares) to just 0.08% (30,000 shares). The company's total equity share capital stands at 3,69,83,500 shares of Rs. 10 each, amounting to Rs. 36.98 crore. The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
The promoter is exiting nearly their entire stake, retaining just 0.08% of the company. While this signals reduced insider commitment, the market impact is limited because the pre-sale holding was already very small at 0.62%.